Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 8—August 2026

Dispatch

Filovirus Surveillance in Communities Bordering Equatorial Guinea, Marburg Outbreak, Cameroon, 2023

Jill-Léa Ramassamy, Flaubert Auguste Mba Djondzo1, Innocent Ndong Bass, Ginette Edoul, Dowbiss Meta-Djomsi, Nadine Lamare, Maeliss Champagne, Célestin Godwe, Kono Léon, Cavour Tadjouteu, Audrey Lacroix, Nicole Vidal, Guillaume Thaurignac, Elisabeth Dibongue, Eric Delaporte, Martine Peeters, Ahidjo Ayouba2, and Charles Kouanfack2
Author affiliation: Université de Montpellier, IRD, INSERM, Montpellier, France (J.-L. Ramassamy, M. Champagne, A. Lacroix, N. Vidal, G. Thaurignac, E. Delaporte, M. Peeters, A. Ayouba); Centre de Recherche sur les Maladies Emergentes et Réémergentes (CREMER), Yaoundé, Cameroon (F.A.M. Djondzo, I.N. Bass, G. Edoul, D. Meta-Djomsi, N. Lamare, C. Godwe, A. Ayouba, C. Kouanfack); University of Yaounde, Yaoundé (K. Léon); Yaoundé Central Hospital, Yaoundé (C. Tadjouteu); Cameroon National OneHealth Platform, Yaoundé (E. Dibongue); University of Dschang, Dschang, Cameroon (C. Kounanfack)

Main Article

Table

MARV antibody responses in captured bats during filovirus surveillance in communities bordering Equatorial Guinea Marburg outbreak, Cameroon, 2023*

MARV antigens
 Bat species

*No. (%) indicates samples above seropositivity thresholds. MARV, Marburg virus; MFI, Median fluorescence intensity; NA, not applicable. †Natural reservoir species for MARV. ‡Includes Epomops franqueti (n = 96), Hypsignathus monstrosus (n = 20), Megaloglossus woermanni (n = 6), Eidolon helvum (n = 2), Hipposideros cyclops (n = 2), Scotonycteris sp. (n = 2), Mops midas (n = 1), Myonycteris torquata (n = 1). No bat samples were reactive to >2 antigens, the criterion for seropositivity in human samples.

Main Article

1These first authors contributed equally to this article.

2These senior authors contributed equally to this article.

Page created: May 28, 2026
Page updated: July 07, 2026
Page reviewed: July 07, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external